# The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers

> **NCT04764201** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 50 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** HIP2001
- **DRUG:** HGP2001

## Key facts

- **NCT ID:** NCT04764201
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-16
- **Primary completion:** 2021-02-26
- **Final completion:** 2021-03-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04764201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04764201, "The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04764201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*